×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DNTH – dianthus therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DNTH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
04:45 am
dnth
Assessing Dianthus Therapeutics (DNTH) Valuation As Price To Book Sits Near 3x And Shares Show Mixed Returns [Yahoo! Finance]
Low
Report
Assessing Dianthus Therapeutics (DNTH) Valuation As Price To Book Sits Near 3x And Shares Show Mixed Returns [Yahoo! Finance]
1/8
12:20 pm
dnth
Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Truist Financial Corporation from $56.00 to $63.00. They now have a "buy" rating on the stock.
Low
Report
Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Truist Financial Corporation from $56.00 to $63.00. They now have a "buy" rating on the stock.
1/7
05:53 pm
dnth
Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run [Yahoo! Finance]
Low
Report
Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run [Yahoo! Finance]
1/5
07:19 am
dnth
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:00 am
dnth
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/23
07:11 am
dnth
Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) [Yahoo! Finance]
Medium
Report
Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) [Yahoo! Finance]
12/23
06:00 am
dnth
Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
Medium
Report
Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
12/22
08:37 am
dnth
Dianthus Therapeutics (NASDAQ:DNTH) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $46.00 price target on the stock.
Medium
Report
Dianthus Therapeutics (NASDAQ:DNTH) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $46.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
09:02 am
dnth
Form 8-K Dianthus Therapeutics, For: Jan 12
Low
Report
Form 8-K Dianthus Therapeutics, For: Jan 12
12/5
08:00 pm
dnth
Form 4 Dianthus Therapeutics, For: Dec 04 Filed by: Savitz Ryan
Low
Report
Form 4 Dianthus Therapeutics, For: Dec 04 Filed by: Savitz Ryan
12/4
04:43 pm
dnth
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
Low
Report
Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
11/25
09:00 pm
dnth
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Fairmount Funds Management LLC
Low
Report
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Fairmount Funds Management LLC
11/19
09:16 pm
dnth
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Avidity Partners Management LP
Low
Report
Form SCHEDULE 13D/A Dianthus Therapeutics, Filed by: Avidity Partners Management LP
11/14
09:00 pm
dnth
Form 4 Dianthus Therapeutics, For: Nov 13 Filed by: Randhawa Simrat
Low
Report
Form 4 Dianthus Therapeutics, For: Nov 13 Filed by: Randhawa Simrat
11/14
04:53 pm
dnth
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Octagon Capital Advisors LP
11/14
04:35 pm
dnth
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: BCLS Fund III Investments, LP
Low
Report
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: BCLS Fund III Investments, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: